Peter W Getsinger

Peter W Getsinger (Director, AGX) sold 6,728 shares for $4,748,497.20 across 2 transactions; retains 4,880 shares + 3,000 option units

Director Peter W Getsinger executed 2 separate sales totaling 6,728 shares for $4,748,497.20 on June 16–17, 2026, at prices of $708.65 and $699.00, reducing his non-derivative holdings by -58.0% from 11,608 to 4,880 shares. The stock is trading at $719.52, up +8.2% over 30 days and +49.9% over 90 days, while trading -7.6% from its 52-week high of $779.00. Looking at his prior 5 trades at AGX, none of the 3 measurable 90-day outcomes were well-timed (all showed positive 90-day returns), suggesting his sales have historically not preceded declines at this ticker. The company's fundamentals show revenue of $290,954,000.00 and net income of $46,063,000.00 in the latest quarter, with a P/E of 62.57 and market cap of $10,087,128,601.44. Getsinger retains derivative holdings of 3,000 shares via options, meaning his overall position is not fully exited.

Director Peter W Getsinger sells 3,000 AGX shares at $628.36; stock now at $669.98 (+0.0% from 52-week high)

Getsinger sold 3,000 shares (representing -32.1% of his pre-transaction holdings of 9,347 shares) for $1.9M on 2026-04-29, leaving him with 6,347 shares. The sale occurred near the stock's 52-week high of $669.98, with current price at $669.98 (+0.0% from that peak). His prior trades at AGX show a consistent pattern: 4 measurable prior sales all resulted in positive 90-day returns (ranging from +12.9% to +87.5%), meaning he has sold before rallies rather than declines—a 0% well-timed rate at this ticker. His cross-ticker history across 7 prior sales shows a 33.33% well-timed rate with an average 90-day return of +30.8%, indicating modest accuracy in timing exits across his broader trading. With AGX trading at a P/E of 54.25 and the recent 30-day and 90-day price changes of +23.0% and +93.0% respectively, the stock has appreciated significantly since this transaction—consistent with his historical pattern of selling into strength.

Director Peter W Getsinger sold 2,581 shares of AGX at $552.73; stock at 52-week high, post-sale holding is 9,847 shares.

Director Peter W Getsinger sold 2,581 shares (representing a -20.8% reduction in his pre-transaction holdings of 12,428 shares) at $552.73 on 2026-04-02, raising $1,426,596.13. The sale occurred at the 52-week high of $575.16, though the actual transaction price of $552.73 reflects a $22.43 discount to current levels. Examining his same-ticker history at AGX, Getsinger has completed 5 prior trades; of 3 measurable 90-day outcomes, only 1 was well-timed (a negative 90-day return), suggesting inconsistent exit timing on this stock. His cross-ticker track record shows 6 prior sells with a 50.00% well-timed rate and an average 90-day return of +5.4%, indicating his sales have generally preceded stock appreciation rather than declines. The company's fundamentals show $251.2M in latest quarterly revenue and a P/E of 46.57, reflecting a premium valuation; the transaction occurred as the stock delivered a +31.0% 30-day return and +76.4% 90-day return, suggesting elevated price levels during the sale window.

Director Peter W Getsinger sold 10,595 shares of AGX across 2 trades for $3,382,277.45 (Jan 7-8), reducing holdings by 57.5%

Director Peter W Getsinger executed two separate sales totaling 10,595 shares for $3,382,277.45 on January 7–8, 2026, at prices of $328.34 and $313.71 respectively (blended average $319.23). This transaction reduced his holdings from 18,442 shares to 7,847 shares, a 57.5% reduction in his stake. The current price of $311.87 sits 21.1% below the 52-week high of $395.20, and the stock has fallen 4.3% over 30 days despite posting a 21.8% gain over 90 days; the director's sales occurred near recent strength. His same-ticker history at AGX shows 2 prior sales in October 2025 that were well-timed at the 30-day mark (returns of +21.8% and +20.4%), though 2 earlier sales in January 2025 showed negative 90-day returns, indicating a mixed record on timing. The company's fundamentals remain robust (revenue of $251,153,000.00, net income of $30,737,000.00, annual revenue growth of +52.5%, and a P/E of 36.10), providing context that this sale does not obviously signal distress, but the substantial reduction in personal ownership deserves monitoring given the director's position.

Director Peter W. Getsinger sold 8,493 shares at $292.00–$294.39 ($2.5M), reducing stake 46.2%, with strong prior same-ticker execution.

Director Getsinger executed 2 separate sales totaling 8,493 shares for $2,495,474.27, reducing his AGX holdings from 18,390 to 9,897 shares (a -46.2% reduction). The transactions occurred on 2025-10-17 and 2025-10-20 at prices materially above the current price of $281.00; at the time of execution, the stock traded near its 52-week high of $312.50. His prior trades at AGX demonstrate consistent execution—both prior sells at this ticker achieved negative 90-day returns (-10.4% and -10.7%), establishing a 100% well-timed rate at this specific ticker. AGX fundamentals remain strong with $237.7M quarterly revenue, $35.3M net income, and 52.5% annual revenue growth, though the elevated P/E of 33.10 reflects rich valuation. The combined signal—substantial reduction at near-52-week highs paired with a two-sale track record of precise timing at this ticker—warrants attention but is not inconsistent with a director managing a concentrated position at elevated valuations.

Director Getsinger sells 8,185 shares across 2 transactions for $1,344,858.65; reduces stake 41.0% to 11,792 shares

Peter W Getsinger, a director of Argan Inc, executed two separate sales totaling 8,185 shares for $1,344,858.65 at blended average price $164.31, reducing his post-transaction holdings to 11,792 shares from 19,977 shares (a 41.0% reduction in stake). The sales occurred on 2025-01-10 and 2025-01-14 as the stock traded within 2% of its 52-week high of $168.04, against a backdrop of strong recent performance (+17.5% in 30 days, +30.0% in 90 days) and elevated valuation metrics (P/E 34.51). The timing and magnitude of the liquidation merit investor attention, as the director retained material holdings while significantly reducing exposure at elevated price levels.